National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts.org
Search Results

This is VAERS ID 367212

Government Disclaimer on use of this data

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

VAERS ID: 367212
VAERS Form:
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 9/14/2017

VAERS ID: 367212 Before After
VAERS Form:(blank) 1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / - UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 2/14/2018

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 6/14/2018

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 8/14/2018

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 9/14/2018

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 10/14/2018

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 12/24/2020

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 12/30/2020

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 5/7/2021

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.


Changed on 5/21/2021

VAERS ID: 367212 Before After
VAERS Form:1
Age:17.0
Sex:Female
Location:Foreign
Vaccinated:2008-10-03
Onset:2009-03-17
Submitted:2009-11-13
Entered:2009-11-13
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HPV2: HPV (CERVARIX) / GLAXOSMITHKLINE BIOLOGICALS - / UNK UN / IM

Administered by: Other      Purchased by: Other
Symptoms: Acute myeloid leukaemia

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Benzydamine hydrochloride
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: UNK
CDC 'Split Type': B0601547A

Write-up: This case was reported by the regulatory authority (# GB-MHRA-ADR 20514963) described the occurrence of acute myeloid leukemia in a 17-year-old female subject who was vaccinated with CERVARIX (GlaxoSmithKline). Concurrent vaccination included CERVARIX given on 26 November 2008. Concurrent medications included DIFFLAM. On 3 October 2008 the subject received an unspecified dose of CERVARIX (.5 ml, intramuscular). On 17 March 2009, approximately 165 days after the vaccination with CERVARIX, the subject experienced acute myeloid leukemia. The regulatory authority reported that the event was life threatening. At the time of reporting the event was improved. Verbatim Text: Coincidental occurrence of leukemia post HPV vaccination. Last administration of CERVARIX was on 26/11/2008.

New Search

Link To This Search Result:

https://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=367212&WAYBACKHISTORY=ON


Copyright © 2022 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166